Northern Survey on Therapeutic Oxygen Prescription (NONSTOP)

Hannover Medical School (MHH)

Status: Unknown

Conditions: Oxygen Toxicity

Treatments: Other: 17 items questionaire

Study type: Observational

Funder types: Other

Identifiers

NCT03937622

Pneumo-O2

Details and patient eligibility

About

This is a prospective multicenter observational trial. Included patients and attending physician complete a standardized questionnaire.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with chronic lung disease, age > 18 years
• Established domiciliary LTOT > 4 weeks
• Scheduled for control of oxygen therapy with arterial/capillary

Exclusion criteria

• No informed consent
• Pulmonary exacerbation within the last 2 weeks
• Signs of heart failure (edema, congestion)